Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Successful use of the Unified Dyskinesia Rating Scale regardless of PD- or dyskinesia-duration.

Ren X, Lin J, Luo S, Goetz CG, Stebbins GT, Cubo E.

Parkinsonism Relat Disord. 2019 Aug 31. pii: S1353-8020(19)30375-X. doi: 10.1016/j.parkreldis.2019.08.019. [Epub ahead of print]

PMID:
31495732
2.

Is Restless Legs Syndrome Associated with an Increased Risk of Mortality? A Meta-Analysis of Cohort Studies.

Cubo E, Gallego-Nieto C, Elizari-Roncal M, Barroso-Pérez T, Collazo C, Calvo S, Delgado-López PD.

Tremor Other Hyperkinet Mov (N Y). 2019 Jul 19;9. doi: 10.7916/tohm.v0.650. eCollection 2019. Review.

3.

Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort.

Santos García D, de Deus Fonticoba T, Suárez Castro E, Borrué C, Mata M, Solano Vila B, Cots Foraster A, Álvarez Sauco M, Rodríguez Pérez AB, Vela L, Macías Y, Escalante S, Esteve P, Reverté Villarroya S, Cubo E, Casas E, Arnaiz S, Carrillo Padilla F, Pueyo Morlans M, Mir P, Martinez-Martin P; Coppadis Study Group.

Parkinsonism Relat Disord. 2019 Jul 29. pii: S1353-8020(19)30351-7. doi: 10.1016/j.parkreldis.2019.07.031. [Epub ahead of print]

PMID:
31409572
4.

COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation.

Santos García D, Jesús S, Aguilar M, Planellas LL, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Catalán MJ, López Díaz L, Puente V, García Moreno JM, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Menéndez González M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues-Boixar O, González Ardura J, Prieto Jurczynska C, Martinez-Martin P, Mir P; COPPADIS Study Group.

Eur J Neurol. 2019 Jun 9. doi: 10.1111/ene.14008. [Epub ahead of print]

PMID:
31179586
5.

Mediating effect of mindfulness cognition on the development of empathy in a university context.

De la Fuente-Anuncibay R, González-Barbadillo Á, González-Bernal J, Cubo E, PizarroRuiz JP.

PLoS One. 2019 Apr 18;14(4):e0215569. doi: 10.1371/journal.pone.0215569. eCollection 2019.

6.

Factors associated with the activation of emergency medical services in patients with acute stroke: a prospective study.

Soto-Cámara R, Trejo-Gabriel-Galán JM, González-Bernal J, González-Santos J, Cubo E.

Emergencias. 2019 Abr;31(2):86-90. English, Spanish.

7.

Clinical manifestations of homozygote allele carriers in Huntington disease.

Cubo E, Martinez-Horta SI, Santalo FS, Descalls AM, Calvo S, Gil-Polo C, Muñoz I, Llano K, Mariscal N, Diaz D, Gutierrez A, Aguado L, Ramos-Arroyo MA; European HD Network.

Neurology. 2019 Apr 30;92(18):e2101-e2108. doi: 10.1212/WNL.0000000000007147. Epub 2019 Mar 13.

PMID:
30867264
8.

Inspiratory Myoclonus.

Dekker MCJ, Kilonzo KG, Howlett WP, Guttman M, Cubo E.

Tremor Other Hyperkinet Mov (N Y). 2019 Feb 18;9:625. doi: 10.7916/3qs5-cv76. eCollection 2019.

9.

Neurological Disorders in Central Spain, Second Survey: Feasibility Pilot Observational Study.

Hernández-Gallego J, Llamas-Velasco S, Bermejo-Pareja F, Vega S, Tapias-Merino E, Rodríguez-Sánchez E, Boycheva E, Serrano JI, Gil-García JF, Trincado R, Sánchez-Rodrigo JV, Cacho J, Contador I, Garcia-Ptacek S, Sierra-Hidalgo F, Cubo E, Carro E, Villarejo-Galende A, García García-Patino R, Benito-León J.

JMIR Res Protoc. 2019 Jan 10;8(1):e10941. doi: 10.2196/10941.

10.

Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations.

Mestre TA, Busse M, Davis AM, Quinn L, Rodrigues FB, Burgunder JM, Carlozzi NE, Walker F, Ho AK, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 May 9;5(4):361-372. doi: 10.1002/mdc3.12617. eCollection 2018 Jul-Aug.

11.

Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.

Mestre TA, Forjaz MJ, Mahlknecht P, Cardoso F, Ferreira JJ, Reilmann R, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the Movement Disorder Society Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 Jan 3;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018 Mar-Apr.

12.

Tarlov cyst and involuntary movements.

Casas E, Arnaiz S, Cubo E.

Rev Clin Esp. 2018 Oct;218(7):382-383. doi: 10.1016/j.rce.2018.03.004. Epub 2018 May 3. English, Spanish. No abstract available.

PMID:
29729879
13.

Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome.

Jiménez-Jiménez FJ, Esguevillas G, Alonso-Navarro H, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Amo G, Rojo-Sebastián A, Rubio L, Díez-Fairén M, Pastor P, Calleja M, Plaza-Nieto JF, Pilo-de-la-Fuente B, Arroyo-Solera M, García-Albea E, Agúndez JAG, García-Martín E.

Pharmacogenomics J. 2018 Jul;18(4):565-577. doi: 10.1038/s41397-018-0023-7. Epub 2018 May 3.

PMID:
29720720
14.

The Promise of Telemedicine for Movement Disorders: an Interdisciplinary Approach.

Ben-Pazi H, Browne P, Chan P, Cubo E, Guttman M, Hassan A, Hatcher-Martin J, Mari Z, Moukheiber E, Okubadejo NU, Shalash A; International Parkinson and Movement Disorder Society Telemedicine Task Force.

Curr Neurol Neurosci Rep. 2018 Apr 13;18(5):26. doi: 10.1007/s11910-018-0834-6. Review.

PMID:
29654523
15.

A 21-Year Retrospective Study of the Toronto Western Hospital Deep Brain Stimulation Cohort.

Cubo E, Rajalingam R, Fasano A, Munhoz RP, Lang AE, Calvo S, Marras C.

Mov Disord. 2018 May;33(5):850-852. doi: 10.1002/mds.27359. Epub 2018 Mar 23. No abstract available.

PMID:
29570864
16.

Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life.

Mestre TA, Carlozzi NE, Ho AK, Burgunder JM, Walker F, Davis AM, Busse M, Quinn L, Rodrigues FB, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2018 May;33(5):742-749. doi: 10.1002/mds.27317. Epub 2018 Mar 23. Review.

17.

Telemedicine Use for Movement Disorders: A Global Survey.

Hassan A, Dorsey ER, Goetz CG, Bloem BR, Guttman M, Tanner CM, Mari Z, Pantelyat A, Galifianakis NB, Bajwa JA, Gatto EM, Cubo E.

Telemed J E Health. 2018 Dec;24(12):979-992. doi: 10.1089/tmj.2017.0295. Epub 2018 Mar 22.

PMID:
29565764
18.

Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.

Catalan MJ, Molina-Arjona JA, Mir P, Cubo E, Arbelo JM, Martinez-Martin P; EDIS Study Group.

J Neurol. 2018 Jun;265(6):1279-1287. doi: 10.1007/s00415-018-8803-1. Epub 2018 Mar 20.

PMID:
29557989
19.

Rating scales for cognition in Huntington's disease: Critique and recommendations.

Mestre TA, Bachoud-Lévi AC, Marinus J, Stout JC, Paulsen JS, Como P, Duff K, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2018 Feb;33(2):187-195. doi: 10.1002/mds.27227. Epub 2017 Dec 26. Review.

PMID:
29278291
20.

Corrigendum to "Mortality and morbidity among hospitalized adult patients with neurological diseases in Cameroon" [J. Neurol. Sci. 381C (2017) 156-168].

Kompoliti K, Doumbe J, Mapoure YN, Nyinyikua T, Ouyang B, Shah H, Calvo S, Fernandez-Sierra A, Cubo E.

J Neurol Sci. 2018 Feb 15;385:237. doi: 10.1016/j.jns.2017.12.001. Epub 2017 Dec 21. No abstract available.

PMID:
29274952
21.

Telemedicine Enables Broader Access to Movement Disorders Curricula for Medical Students.

Cubo E, Doumbe J, López E, Lopez GA, Gatto E, Persi G, Guttman M.

Tremor Other Hyperkinet Mov (N Y). 2017 Oct 19;7:501. doi: 10.7916/D8708CXW. eCollection 2017.

22.

Association Between the rs1229984 Polymorphism in the Alcohol Dehydrogenase 1B Gene and Risk for Restless Legs Syndrome.

Jiménez-Jiménez FJ, Gómez-Tabales J, Alonso-Navarro H, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Díez-Fairén M, Pastor P, Calleja M, Plaza-Nieto JF, Pilo-de-la-Fuente B, Arroyo-Solera M, García-Albea E, Agúndez JAG, García-Martín E.

Sleep. 2017 Dec 1;40(12). doi: 10.1093/sleep/zsx174.

PMID:
29045753
23.

[Quality of life and associated characteristics of restless legs syndrome in the adult population of Burgos, Spain].

Barroso-Perez MT, Cubo E, Cordero-Guevara J, Poza-Maure E, Checa-Diez L.

Rev Neurol. 2017 Sep 16;65(6):257-262. Spanish.

24.

[Efficacy of a dynamic orthosis on the upper limbs in the chronic phase of strokes. A longitudinal study].

Gonzalez-Bernal J, de la Fuente-Anuncibay R, Gonzalez-Santos J, Cuesta-Gomez JL, Cubo E.

Rev Neurol. 2017 Sep 1;65(5):209-215. Spanish.

25.

The Association of Poor Academic Performance with Tic Disorders: A Longitudinal, Mainstream School-Based Population Study.

Cubo E, Gonzalez C, Ausin V, Delgado V, Saez S, Calvo S, Garcia Soto X, Cordero J, Kompoliti K, Louis ED, de la Fuente Anuncibay R.

Neuroepidemiology. 2017;48(3-4):155-163. doi: 10.1159/000479517. Epub 2017 Jul 29.

PMID:
28768287
26.

Factors associated with Mediterranean diet adherence in Huntington's disease.

Rivadeneyra J, Cubo E, Gil C, Calvo S, Mariscal N, Martínez A.

Clin Nutr ESPEN. 2016 Apr;12:e7-e13. doi: 10.1016/j.clnesp.2016.01.001. Epub 2016 Mar 5.

PMID:
28531758
27.

New neurosurgical approaches for tremor and Parkinson's disease.

Fasano A, Lozano AM, Cubo E.

Curr Opin Neurol. 2017 Aug;30(4):435-446. doi: 10.1097/WCO.0000000000000465. Review.

PMID:
28509682
28.

The Burden of Movement Disorders in Cameroon: A Rural and Urban-Based Inpatient/Outpatient Study.

Cubo E, Doumbe J, Mapoure Njankouo Y, Nyinyikua T, Kuate C, Ouyang B, Shah H, Calvo S, Fernandez-Sierra A, Kompoliti K, Njiengwe E, Louis ED.

Mov Disord Clin Pract. 2017 Mar 11;4(4):568-573. doi: 10.1002/mdc3.12474. eCollection 2017 Jul-Aug.

29.

Response to letter by Saenz-Farret et al. on "Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations".

Mestre TA, van Duijn E, Davis AM, Bachoud-Lévi AC, Busse M, Anderson KE, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2017 Mar;32(3):482. doi: 10.1002/mds.26954. Epub 2017 Mar 3. No abstract available.

PMID:
28256103
30.

Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for restless legs syndrome.

Jiménez-Jiménez FJ, García-Martín E, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Ortega-Cubero S, Pastor P, Calleja M, Plaza-Nieto JF, Pilo-de-la-Fuente B, Arroyo-Solera M, García-Albea E, Agúndez JA.

J Neural Transm (Vienna). 2017 Mar;124(3):285-291. doi: 10.1007/s00702-016-1645-z. Epub 2016 Nov 11.

PMID:
27837280
31.

Spanish Validation of the Problem Behaviors Assessment-Short (PBA-s) for Huntington's Disease.

Ruiz-Idiago JM, Floriach M, Mareca C, Salvador R, López-Sendón JL, Mañanés V, Cubo E, Mariscal N, Muñoz E, Santacruz P, Noguera MF, Vivancos L, Roy P, Pomarol-Clotet E, Sarró S; Spanish Huntington Disease Network.

J Neuropsychiatry Clin Neurosci. 2017 Winter;29(1):31-38. doi: 10.1176/appi.neuropsych.16020025. Epub 2016 Jul 15.

PMID:
27417071
32.

Clinical manifestations of intermediate allele carriers in Huntington disease.

Cubo E, Ramos-Arroyo MA, Martinez-Horta S, Martínez-Descalls A, Calvo S, Gil-Polo C; European HD Network.

Neurology. 2016 Aug 9;87(6):571-8. doi: 10.1212/WNL.0000000000002944. Epub 2016 Jul 8.

PMID:
27402890
33.

Wearable Sensors for Advanced Therapy Referral in Parkinson's Disease.

Heldman DA, Giuffrida JP, Cubo E.

J Parkinsons Dis. 2016 Jul 2;6(3):631-8. doi: 10.3233/JPD-160830.

PMID:
27392872
34.

Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.

Mestre TA, van Duijn E, Davis AM, Bachoud-Lévi AC, Busse M, Anderson KE, Ferreira JJ, Mahlknecht P, Tumas V, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2016 Oct;31(10):1466-1478. doi: 10.1002/mds.26675. Review.

PMID:
27296904
35.

Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.

Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group.

BMC Neurol. 2016 Apr 6;16:44. doi: 10.1186/s12883-016-0567-6. No abstract available.

36.

Prospective study on cost-effectiveness of home-based motor assessment in Parkinson's disease.

Cubo E, Mariscal N, Solano B, Becerra V, Armesto D, Calvo S, Arribas J, Seco J, Martinez A, Zorrilla L, Heldman D.

J Telemed Telecare. 2017 Feb;23(2):328-338. doi: 10.1177/1357633X16638971. Epub 2016 Jul 8.

PMID:
27000142
37.

COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.

Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group.

BMC Neurol. 2016 Feb 25;16:26. doi: 10.1186/s12883-016-0548-9. Erratum in: BMC Neurol. 2016;16:44.

38.

Factors Associated with Low Body Mass Index in Huntington's Disease: A Spanish Multicenter Study of the European Huntington's Disease Registry.

Cubo E, Rivadeneyra J, Mariscal N, Martinez A, Armesto D, Camara RJ; Spanish Members of the European Huntington's Disease Registry.

Mov Disord Clin Pract. 2016 Jan 18;3(5):452-459. doi: 10.1002/mdc3.12304. eCollection 2016 Sep-Oct.

39.

Parkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model Analysis.

Martinez-Martín P, Rodriguez-Blazquez C, Paz S, Forjaz MJ, Frades-Payo B, Cubo E, de Pedro-Cuesta J, Lizán L; ELEP Group.

PLoS One. 2015 Dec 23;10(12):e0145310. doi: 10.1371/journal.pone.0145310. eCollection 2015.

40.

Association Between Vitamin D Receptor rs731236 (Taq1) Polymorphism and Risk for Restless Legs Syndrome in the Spanish Caucasian Population.

Jiménez-Jiménez FJ, García-Martín E, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Ortega-Cubero S, Pastor P, Calleja M, Plaza-Nieto JF, Pilo-De-La-Fuente B, Arroyo-Solera M, García-Albea E, Agúndez JA.

Medicine (Baltimore). 2015 Nov;94(47):e2125. doi: 10.1097/MD.0000000000002125.

41.

Body composition analysis as an indirect marker of skeletal muscle mass in Huntington's disease.

Cubo E, Rivadeneyra J, Gil-Polo C, Armesto D, Mateos A, Mariscal-Pérez N.

J Neurol Sci. 2015 Nov 15;358(1-2):335-8. doi: 10.1016/j.jns.2015.09.351. Epub 2015 Sep 15.

PMID:
26394908
42.

Relationship between Nutritional Status and the Severity of Huntington’s Disease. A Spanish Multicenter Dietary Intake Study.

Cubo E, Rivadeneyra J, Armesto D, Mariscal N, Martinez A, Camara RJ; Spanish members of the European Huntington Disease Network.

J Huntingtons Dis. 2015;4(1):78-85.

PMID:
26333259
43.

Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Restless Legs Syndrome.

García-Martín E, Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Ortega-Cubero S, Pastor P, Calleja M, Plaza-Nieto JF, Pilo-de-la-Fuente B, Arroyo-Solera M, García-Albea E, Agúndez JA.

Medicine (Baltimore). 2015 Aug;94(34):e1448. doi: 10.1097/MD.0000000000001448.

44.

A Parkinson's disease tele-education program for health care providers in Cameroon.

Cubo E, Doumbe J, Njiengwe E, Onana P, Garoña R, Alcalde J, Seco J, Mariscal N, Epundugu BM, Cubo S, Coma MJ.

J Neurol Sci. 2015 Oct 15;357(1-2):285-7. doi: 10.1016/j.jns.2015.07.019. Epub 2015 Jul 15.

PMID:
26190525
45.

Analysis of the Reasons for Non-Uptake of Predictive Testing for Huntington's Disease in Spain: A Qualitative Study.

Rivera-Navarro J, Cubo E, Mariscal N.

J Genet Couns. 2015 Dec;24(6):1011-21. doi: 10.1007/s10897-015-9840-x. Epub 2015 Apr 30.

PMID:
25921556
46.

Prenatal and Perinatal Morbidity in Children with Tic Disorders: A Mainstream School-based Population Study in Central Spain.

Cubo E, Hortigüela M, Jorge-Roldan S, Ciciliani SE, Lopez P, Velasco L, Sastre E, Ausin V, Delgado V, Saez S, Gabriel-Galán JT, Macarrón J.

Tremor Other Hyperkinet Mov (N Y). 2014 Dec 15;4:272. doi: 10.7916/D8FN14W9. eCollection 2014.

47.

Head and Arm Tremor in X-linked Spinal and Bulbar Muscular Atrophy.

Aicua I, Verhagen O, Arenaza N, Cubo E.

Tremor Other Hyperkinet Mov (N Y). 2014 Oct 8;4:265. doi: 10.7916/D8959FVJ. eCollection 2014.

48.

Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for restless legs syndrome.

Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Calleja M, Plaza-Nieto JF, Pilo-de-la-Fuente B, Arroyo-Solera M, García-Albea E, García-Martín E, Agúndez JA.

J Neural Transm (Vienna). 2015 Jun;122(6):819-23. doi: 10.1007/s00702-014-1322-z. Epub 2014 Oct 10.

PMID:
25300364
49.

Independent Spanish Validation of the Unified Dyskinesia Rating Scale.

Cubo E, Goetz CG, Stebbins GT, LaPelle NR, Tilley BC, Wang L, Luo S.

Mov Disord Clin Pract. 2014 Sep;1(3):213-218. Epub 2014 Aug 5.

50.

The past, present, and future of telemedicine for Parkinson's disease.

Achey M, Aldred JL, Aljehani N, Bloem BR, Biglan KM, Chan P, Cubo E, Dorsey ER, Goetz CG, Guttman M, Hassan A, Khandhar SM, Mari Z, Spindler M, Tanner CM, van den Haak P, Walker R, Wilkinson JR; International Parkinson and Movement Disorder Society Telemedicine Task Force.

Mov Disord. 2014 Jun;29(7):871-83. doi: 10.1002/mds.25903. Epub 2014 May 17. Review.

PMID:
24838316

Supplemental Content

Support Center